| Results summary | View all lists in L2L MDB | View all genes in C05AA.profile.d50 |
|
Up-regulated 4 hr following treatment of human microvessel endothelial cells (HMVEC) with TGFbeta. enrichment: 1.82-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 209369_AT | ANXA3 | S | annexin A3 | ||||||||||
| 212593_S_AT | PDCD4 | G | R | programmed cell death 4 (neoplastic transformation inhibitor) | |||||||||
| 218521_S_AT | UBE2W | P | ubiquitin-conjugating enzyme E2W (putative) | ||||||||||
| 209635_AT | AP1S1 | T | adaptor-related protein complex 1, sigma 1 subunit | ||||||||||
| 203439_S_AT | STC2 | C | S | stanniocalcin 2 | |||||||||
| 201341_AT | ENC1 | D | ectodermal-neural cortex (with BTB-like domain) | ||||||||||
| 215220_S_AT | TPR | T | translocated promoter region (to activated MET oncogene) | ||||||||||
| 201340_S_AT | ENC1 | D | ectodermal-neural cortex (with BTB-like domain) | ||||||||||
| 203373_AT | SOCS2 | G | S | suppressor of cytokine signaling 2 | |||||||||